This barrier is the "gatekeeper" of your gut
The FDA approved oral semaglutide (Rybelsus) in 2019, and other oral GLP-1 medications like orforglipron are in development
Therefore, if partaking in a high intensity sport or high intensity physical exercise, it can improve performance and results
Low Dose Range (20-40 mcg): Research at this dose range has often shown good tolerability with minimal adverse effects
If your provider wants you at 1.25mg (a common starting microdose), you draw exactly 25 units
Further, there is no indication of medical efficacy of these unregistered products with GLP-1 claims, in particular for weight-loss. The TGA urges consumer caution when purchasing medicines from unknown overseas websites, suggesting these products could be fake, contain incorrect or undisclosed and harmful ingredients, and may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia